NLRP3 and diabetic retinopathy: Therefore, our findings provide new insights into the mechanisms involved in the migration, apoptosis and pyroptosis of hRMECs and demonstrate that H3 relaxin is a potential therapeutic agent for ameliorating the activation of the NLRP3 inflammasome associated with high glucose, especially that in AGE-BSA-induced diabetic retinopathy.